This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




Text Version  RSS  Subscribe  Unsubscribe  Archive  Media Kit June 19, 2015
Home    About AST    Education    Meetings & Events    Public Policy    Contact Us  

 



SOCIETY NEWS

The AST welcomes Boudreau and Covington to National Office
AST
The AST recently added two new executives to the management team: Mike Boudreau as chief operating officer and Shandie Covington as executive director.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




Pay it Forward
AST
"Transplantation is an enormously complicated field that relies on the participation of physicians, surgeons, researchers and others. In order to advance, all who participate on the transplant team must continue the dialogue. Cooperation among transplant professionals is what has set AST apart from other societies." - AST founding President Dr. Ronald Guttmann

Pay it forward and continue the dialogue as we work together to improve human life by advancing the field of transplantation. Invite your colleagues to join AST and actively participate in the growth of our knowledge and Society.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
 
You care about your transplant patients. And so do we. That’s why we’re introducing Astellas Cares—a new program that offers you customized tools, educational resources, and comprehensive support to help your patients care for their health. To register, visit AstellasCares.com/Transplant today.
 


Have you paid your 2015 membership dues?
AST
Friendly reminder to those AST members who have not yet paid 2015 dues: please note that your membership will be terminated as of December 31, 2015 if your dues payment is not received. If you are not sure if you have paid to date, please contact the AST Membership Team at info@myAST.org.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PRODUCT SHOWCASE
  UCLA Immunogenetics Center

The UCLA Immunogenetics Center (UIC) provides comprehensive testing for organ and tissue transplantation. Transplant testing has a long history at UCLA. HLA typing was pioneered here in the 1960's. The development of the microcytoxicity test in 1964 marked the beginning of international testing and standardization of HLA typing. The UCLA Immunogenetics Center has retained its leadership position in HLA research, and in the development of accompanying diagnostic testing. MORE
 


UPCOMING EVENTS IN TRANSPLANTATION

AST Fellows Symposium - SAVE THE DATE!
AST
Sept. 25-27, 2015 | Grapevine, TX
For more information: www.myAST.org/fellows

ASHI 41st Annual Meeting
ASHI
Sept. 28 - October 2, 2015 | Savannah, GA
For more information: http://www.ashi-hla.org/events/annual-meeting/

2015 Banff/CST Joint Meeting
CST
Oct. 5-10, 2015 | Vancouver
For more information: http://www.cst-transplant.ca/meetings_asm.html

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PRODUCT SHOWCASE
  Missing or Broken Doppler Probes?

VTI’s disposable intraoperative Doppler probes are ready to verify technical results. There’s no longer the need to perform sterilization that frequently causes irreversible damage to the traditional Doppler probes. Advantages include fewer replacements of conventional Doppler probes damaged during sterilization, OR time saved, and a reduction in specialty procedures.
 


TRANSPLANT NEWS


Landscape of deceased donors labeled increased risk for disease transmission under new guidelines
American Journal of Transplantation
Deceased donors are labeled increased risk for disease transmission if they meet certain criteria. New PHS guidelines were recently implemented; the impact of these changes remains unknown. We aimed to quantify the impact of the new guidelines on the proportion of deceased donors labeled IRD, as well as demographic and clinical characteristics.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




The synergistic effect of class II HLA epitope-mismatch and nonadherence on acute rejection and graft survival
American Journal of Transplantation
Predicting long-term outcomes in renal transplant recipients is essential to optimize medical therapy and determine the frequency of posttransplant histologic and serologic monitoring. Nonadherence and human leukocyte antigen (HLA) mismatch are risk factors that have been associated with poor long-term outcomes and may help individualize care.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Influence of sex and race on mycophenolic acid pharmacokinetics in stable African American and Caucasian renal transplant recipients
Clinical Pharmacokinetics
No evaluation of sex and race influences on mycophenolic acid (MPA) pharmacokinetics and adverse effects (AEs) during enteric-coated mycophenolate sodium (ECMPS) and tacrolimus immunosuppression are available. The primary objective of this study was to investigate the influence of sex and race on MPA and MPA glucuronide (MPAG) pharmacokinetics in stable renal transplant recipients receiving ECMPS and tacrolimus.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


COMMITMENT TO CARE
Raptor's mission is to develop and commercialize life-altering therapeutics that treat rare, debilitating, and often fatal diseases.
LEARN MORE
Advertise here!

To find out how to feature your company in the AST eNewsletter and other advertising opportunities, Contact Tom Crist at 972-402-7724.
MORE


Total joint arthroplasty in transplant recipients: In-hospital adverse outcomes
The Journal of Arthroplasty
This study aims to determine in-hospital complications and mortality in transplant recipients following total joint arthroplasty. The Nationwide Inpatient Sample database was queried for patients with history of transplant and joint arthroplasty (primary or revision) from 1993 to 2011.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Impact of the new Fast Track Kidney Allocation Scheme for declined kidneys in the United Kingdom
Clinical Transplantation
A ‘new’ Fast Tract Kidney Allocation Scheme (FTKAS) was implemented in the U.K. in 2012 for offering of previously declined kidneys. We evaluated the impact of the FTKAS in utilization of declined kidneys and outcome. Adult renal transplant centers were surveyed. Overall utilization was evaluated using NHSBT data. Outcome of FTKAS kidneys in our center was analysed.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    AST Past-President Kenneth Newell featured in USA Today supplement on transplantation (AST)
Effect of lung transplantation on heart rate response to exercise (Heart & Lung: The Journal of Acute and Critical Care)
The effect of state policies on organ donation and transplantation in the United States (JAMA)
New blog post: Words of Caution on HOPE Act Implementation (AST)
Energy expenditure, spontaneous physical activity and with weight gain in kidney transplant recipients (Clinical Nutrition)

Don't be left behind. Click here to see what else you missed.
 



AST eNews

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Julie Bernhard, Executive Editor, 469.420.2647  
Contribute news


This edition of the AST eNews was sent to ##Email##. To unsubscribe, click here.

Recent issues
June 12, 2015
June 5, 2015
May 29, 2015
May 22, 2015



Advertisement



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063